4.5 Article

Herpes virus in Alzheimer's disease: relation to progression of the disease

Journal

NEUROBIOLOGY OF AGING
Volume 35, Issue 1, Pages 122-129

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2013.06.024

Keywords

Alzheimer's disease; Herpes virus latency; Quantitative real time PCR; Nested PCR; Peripheral blood samples; Brain tissue samples; Inflammatory plasma markers and cognitive decline

Funding

  1. Italian Ministry for University and Research, Italy
  2. CARISBO Foundation Bologna, Italy
  3. BRACCO Pharmaceutics Milano, Italy

Ask authors/readers for more resources

Studies regarding different viruses of the herpes family, such as cytomegalovirus (CMV), Epstein-Barr virus (EBV), or human herpes virus 6 (HHV-6) in Alzheimer's disease (AD) are scarce. DNA from peripheral blood leukocytes (PBL) and brain samples were analyzed for the presence of CMV, EBV, or HHV-6. All samples were negative for CMV. EBV positivity was 6% in AD brains, whereas 45% of PBL samples from AD patients and 31% from controls were positive for EBV (p = 0.05). HHV-6 showed a 23% positivity in PBL samples from AD and 4% from controls (p = 0.002). 17% of AD brains were HHV-6 positive. Within a group of elderly individuals, followed up for 5 years, EBV-positive or HHV-6-positive PBL increased in those who developed clinical AD. Virus serological positivity was also investigated, and IgG levels for CMV and EBV antigens were also increased in those subjects who developed AD during the follow-up. Our findings suggest that EBV and HHV-6 may be environmental risk factors for cognitive deterioration and progression to AD in elderly persons. (c) 2014 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available